Extending indications for long-term pharmacotherapy: opportunities and challenges.
about
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmMono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSPQuetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction.Antidepressant treatment for acute bipolar depression: an update.Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.Relapse prevention in bipolar disorder: a critical review of current guidelines.Oxcarbazepine in bipolar disorder: a critical review of the literature.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyRandomized controlled trial of a health plan-level mood disorders psychosocial intervention for solo or small practices.Lamotrigine in the treatment of bipolar disorder.Cluster randomized controlled trial of a psycho-educational intervention for people with a family history of depression for use in general practice.Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disordersNew anticonvulsant medication uses in bipolar disorder.New medication treatment options for bipolar disorders.Bipolar II disorder: an overview of recent developments.Assessment tools for screening and monitoring bipolar disorder.Women are not the same as men: specific clinical issues for female patients with bipolar disorder.Perceived quality of life in patients with bipolar disorder. Does group psychoeducation have an impact?Lithium - a continuing story in the treatment of bipolar disorder.Bipolar mixed states and their treatment.Pharmacotherapy of bipolar mixed states.Bipolar disorder in women: reproductive events and treatment considerations.Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation.Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.Safety and tolerability of mood-stabilising anticonvulsants in the elderly.Practical considerations for carbamazepine use in bipolar disorder.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.Family-focused treatment of the suicidal bipolar patient.Zonisamide for bipolar depression.Historical review of carbamazepine for the treatment of bipolar disorder.Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin.Off-label prescription of quetiapine in psychiatric disorders.Maintenance treatment in bipolar disorder: a focus on aripiprazole.Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depressionMood stabilizer loading versus titration in acute mania: audit of clinical practice.Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.
P2860
Q28066714-9EA0D0E0-BCD3-4BE1-85CB-77D62AAC690CQ30569917-827D6F1E-4126-413E-8342-4B683E6D0759Q31127921-492E7C9C-012B-4BA1-9D9B-2A33CCA9DE07Q33268080-3CA73473-B129-4434-9CDD-155C9E6A4241Q34022325-02F27B71-1FE1-44C7-8788-BF520B978D58Q34154885-7F465BD3-8FFE-46BC-BBFF-B65925F91095Q34197988-77E44204-0617-4D7D-B7CC-9CA5A520BB3CQ34504000-63E9C951-D0FC-4746-96B7-62DB80831342Q34610837-73242E40-1361-4911-B14F-C26BED6A3538Q34676317-06E40DD1-B5F6-465C-850B-9191D39857E4Q34707121-037564E1-3C45-470A-B023-9E765B8F4E7FQ34974841-49B34D81-5926-46EE-818F-DFC35CBACFD8Q35056717-C84285A7-A75D-4809-85B8-E8C42D2F325EQ35180787-19D183D6-7394-4E83-B174-587C722BCE26Q35334500-B788F0CC-53C8-4F88-AFE5-7F7CC1A4653CQ35673095-9192FD51-FE1B-4501-BA39-6ABC85135EB6Q35872066-BDA36BE6-3D2B-4719-8A5B-FD0264D60FB3Q36023392-B25E2367-15F7-4C6D-97A7-321C0B867A10Q36068762-F601A5DD-3A08-4B53-B7B7-7D6A9B1EF184Q36068766-1FF351A9-15C3-4CA3-8E8D-F6D6CBD1DCE0Q36088071-B285BE5C-FA20-42D7-9220-C17C059A1FEBQ36099532-5B07868D-81F4-4827-8996-719105CA1E5AQ36106765-E03E03B8-9D44-49C5-8D43-6ED50CC0DD57Q36130303-E3027843-6580-4174-B10A-AAEC5C066BACQ36181505-36DD9EFC-A68E-4CED-BBC3-8D3D9EC90C2CQ36251776-EBADB9B1-58F4-4FA4-8C94-88134C472EFAQ36257188-5AE04500-F630-4C75-AE0F-0907D0CD1181Q36446899-633660FF-322E-42DC-8C04-EB80C3066B21Q36506812-3FD455FF-455C-4D49-9A04-B730D2EC67C1Q36603317-C3109784-C2C6-4233-923D-FBC9EC7EF59AQ36606791-656F6154-BB90-474F-8505-26ADCA394A15Q36624150-02B9478D-F9E6-4CDE-B276-970A4BBE9017Q36681343-2E496E02-9768-488E-ACC4-BA152ECFA9D8Q36693846-B2C40B08-A938-457C-AE25-81A1062F5619Q36762432-4AD8E118-A41B-4F84-9F8D-E5F9472280EBQ36870068-2CD2CFB7-9F9B-4E73-A0C3-E9AC4B5C24FAQ36902005-B6D7F1F1-287B-4C33-A796-ADDB2AACED95Q37201555-4F102282-0C12-4AD3-8C30-4AD2C9BAA68CQ37305546-4C5A4150-29D4-496D-A72B-7398A6466EEAQ37426143-4F17F33E-21CF-434B-B5F7-77FF25F9925A
P2860
Extending indications for long-term pharmacotherapy: opportunities and challenges.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@en
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@nl
type
label
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@en
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@nl
prefLabel
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@en
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@nl
P356
P1476
Extending indications for long-term pharmacotherapy: opportunities and challenges.
@en
P2093
John M Kane
P356
10.1176/APPI.AJP.159.1.1
P407
P577
2002-01-01T00:00:00Z